Bcrx stocktwits
8 Wall Street analysts have issued ratings and price targets for BioCryst Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.93, suggesting that the stock has a possible upside of 177.28%. The high price target for BCRX is $15.00 and the low price target for BCRX is $4.00. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and